Back to Results
First PageMeta Content
Health / ALS Therapy Development Institute / 3 / 4-Methylenedioxyamphetamine / Neuroscience / ALS Society of Canada / ALS Association / Rare diseases / Muscular Dystrophy Association / Amyotrophic lateral sclerosis


MDA ALS Division logo_cmyk
Add to Reading List

Document Date: 2014-02-20 10:53:47

Open Document

File Size: 2,21 MB

Share Result on Facebook

City

San Francisco / Cambridge / Houston / Boston / /

Company

California Pacific Medical Center / MDA National Campaign / Twitter / Facebook / Muscular Dystrophy Association Inc. / YouTube / /

Currency

USD / /

Facility

Massachusetts General Hospital / MDA clinic / Methodist Neurological Institute / Columbia University / ALS Therapy Development Institute / Emory University / /

IndustryTerm

medical management / durable medical equipment / medical services / cellular energy factories / /

MedicalCondition

myotrophic lateral sclerosis / Lou Gehrig’s disease / disease / serious disease / ALS / diseases / multisystem neurodegenerative disorder / /

MedicalTreatment

stem cell therapy / drug therapy / /

Organization

U.S. Food and Drug Administration / ALS Therapy Development Institute / Methodist Neurological Institute / Emory University / Atlanta / Massachusetts General Hospital / Columbia University / New York / /

Person

Eleanor Gehrig / Lou Gehrig / /

/

Position

Leader / Chairman / first baseman / /

Product

riluzole / Rilutek / /

ProvinceOrState

New York / Massachusetts / /

PublishedMedium

Milestones / /

Technology

cell therapy / drug development / /

URL

alsn.mda.org / als.mda.org / /

SocialTag